-
841
First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer
Published 2025-01-01“…CD47 and CD40 target engagement on CD4+ T cells and B cells, respectively, approached 100% by 3.0 mg/kg. …”
Get full text
Article -
842
Single-cell mitophagy patterns within the tumor microenvironment modulate intercellular communication, impacting the progression and prognosis of hepatocellular carcinoma
Published 2025-01-01“…Mitophagy-related CAFs, TAMs, CD8+ T cells, and B cells were identified. These subtypes had different biological states, cell-cell communications, and metabolic pathways. …”
Get full text
Article -
843
Cross-species comparisons between pigs and mice reveal conserved sex-specific intraspinal inflammatory responses after spinal cord injury
Published 2025-01-01“…No differences were seen for astrocytes, microglia, macrophages, B-cells, and neutrophil infiltration between males and females. …”
Get full text
Article -
844
Role of Microglia in CNS Autoimmunity
Published 2013-01-01“…The disease is characterized histologically by the infiltration of encephalitogenic TH1/TH17-polarized CD4+ T cells, B cells, and a plethora of myeloid cells, resulting in severe demyelination ultimately leading to a degeneration of neuronal structures. …”
Get full text
Article -
845
Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study
Published 2025-02-01“…Clinical measures included: MRI activity, annualized relapse rate (ARR), 6-month confirmed disability progression (6mCDP), timed 25-foot walk (T25FW), and 9-hole peg test (9HPT).ResultsAll B, T and NK cells were reduced at month (M)3 after CladT administration, except regulatory B cells which increased above BL from M3 to M24. Naïve and transitional B cells recovered at M6; all other B and T cell subsets remained below BL levels. …”
Get full text
Article -
846
Role of Inflammatory Cell Subtypes in Heart Failure
Published 2019-01-01“…Various types of immune cells are implicated in myocardial inflammation and include neutrophils, macrophages, eosinophils, mast cells, natural killer cells, T cells, and B cells. Recent clinical trials have targeted inflammatory cascades as therapy for heart failure with limited success. …”
Get full text
Article -
847
A Pediatric Case of Systemic Lupus Erythematosus Developed 10 Years after Cord Blood Transplantation for Juvenile Myelomonocytic Leukemia
Published 2012-01-01“…Genetic analysis of peripheral blood revealed mixed chimera with recipient cells consisting of <5% of T cells, 50–60% of B cells, 60–75% of NK cells, 70–80% of macrophages, and 50–60% of granulocytes. …”
Get full text
Article -
848
A Case of Primary T-Cell Central Nervous System Lymphoma: MR Imaging and MR Spectroscopy Assessment
Published 2013-01-01“…Primary central nervous system lymphomas (PCNSLs) are mainly B-cells lymphomas. A risk factor for the development of PCNSL is immunodeficiency, which includes congenital disorders, iatrogenic immunosuppression, and HIV. …”
Get full text
Article -
849
Prostate cancer cells elevate glycolysis and G6PD in response to caffeic acid phenethyl ester-induced growth inhibition
Published 2025-01-01“…Results Seahorse Bioenergetics analysis revealed that ECAR, glycolysis, OCR, and ATP production were elevated in C4-2B cells under CAPE treatment. Protein levels of glucose-6-phosphate dehydrogenase (G6PD), phosphogluconate dehydrogenase (PGD), glutaminase (GLS), phospho-AMPK Thr172 as well as abundance of pyruvate, lactate, ribulose-5-phosphate, and sedoheptulose-7-phosphate were increased in CAPE-treated C4-2B cells. …”
Get full text
Article -
850
Nrf2/cyclooxygenase 2 signaling in Cr(VI)-induced carcinogenesis
Published 2025-02-01“…The results indicated that COX-2 functioned as an oncogene to promote the malignant transformation of B2B cells and enhance the proliferation, migration, tumor growth, and angiogenesis of Cr-T cells. …”
Get full text
Article -
851
Autoimmune Cytopenias in Chronic Lymphocytic Leukemia
Published 2013-01-01“…The source of autoantibodies is still uncertain, despite the most convincing data are in favor of the involvement of resting normal B-cells. In general, excluding the specific treatment of underlying CLL, the managementof these complications is not different from that of idiopathic autoimmune cytopenias or of those associated to other causes. …”
Get full text
Article -
852
Concurrent Hairy Cell Leukemia and Metastatic Merkel Cell Carcinoma
Published 2018-01-01“…HCL is a lymphoid malignancy of mature B cells, and MCC derives from neuroendocrine cell origin. …”
Get full text
Article -
853
Borrelia burgdorferi sensu lato inhibits CIITA transcription through pSTAT3 activation and enhanced SOCS1 and SOCS3 expression leading to limited IFN-γ production
Published 2025-01-01“…While STAT3 phosphorylation was highly induced in T cells, B cells and NK-(T) cells, STAT1 expression and IL-12p70 production were not or only slightly increased upon B. burgdorferi s.l. exposure. …”
Get full text
Article -
854
KMO-driven metabolic reconfiguration and its impact on immune cell infiltration in nasopharyngeal carcinoma: a new avenue for immunotherapy
Published 2025-02-01“…Single-cell transcriptomic analysis revealed that KMO was primarily expressed in B cells, with some contribution from myeloid cells. …”
Get full text
Article -
855
Th9 Cells in Peripheral Blood Increased in Patients with Immune-Related Pancytopenia
Published 2020-01-01“…They were negatively correlated with hemoglobin, red blood cell, white blood cell, and platelet counts and positively correlated with the percentage of CD19+B cells and CD5+CD19+/CD19+B cells, respectively. …”
Get full text
Article -
856
Effects of Macrofungal Polysaccharides Combined with Vemurafenib on Melanoma and Its Associated Mechanism
Published 2019-01-01“…In addition, the combination of MFPS1 and Vemurafenib can enhance the immunomodulatory activity of melanoma-bearing mice as well as elicit the activation and proliferation of B cells and T cells.…”
Get full text
Article -
857
Toll-Like Receptor 2 as a Regulator of Oral Tolerance in the Gastrointestinal Tract
Published 2014-01-01“…This review focuses on recent advances in our understanding of the relationship between TLR2 and oral tolerance, with an emphasis on regulatory T cells, eosinophils, B cells, IgA, intestinal regulation, and commensal microbes.…”
Get full text
Article -
858
CD19-directed chimeric antigen receptor T-cell therapy: what can we learn from the haematologist?
Published 2025-01-01“…By selectively depleting CD19-positive B-cells, this therapy brings a new approach in resetting immune dysregulation and potentially providing long-term remission for patients with a refractory disease. …”
Get full text
Article -
859
Biomimetic insulin-imprinted polymer nanoparticles as a potential oral drug delivery system
Published 2017-06-01“…In this study, we investigate molecularly imprinted polymers (MIPs), which form a three-dimensional image of the region at and around the active binding sites of pharmaceutically active insulin or are analogous to b cells bound to insulin. This approach was employed to create a welldefined structure within the nanospace cavities that make up functional monomers by cross-linking. …”
Get full text
Article -
860
A Meta-analysis of the Effect of Probiotic <i>Lactobacillus</i> sp. as Immunomodulating Inflammatory Responses
Published 2024-06-01“…Lactobacillus sp. has a positive effect on B cells, eosinophils, IgE, NK cells, TNF-α, and IL-10. …”
Get full text
Article